1 / 11

Effects of Listing and Delisting in National Essential Medicine List on Utilization Patterns

Effects of Listing and Delisting in National Essential Medicine List on Utilization Patterns. Sauwakon Ratanawijitrasin , PhD and Sanita Hirunrassamee , PhD. Background. Objective . To examine the effects of NEML listing and delisting on the utilization patterns comparing:

xenos
Download Presentation

Effects of Listing and Delisting in National Essential Medicine List on Utilization Patterns

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Effects of Listing and Delisting in National Essential Medicine List on Utilization Patterns SauwakonRatanawijitrasin, PhD and SanitaHirunrassamee, PhD

  2. Background

  3. Objective To examine the effects of NEML listing and delisting on the utilization patterns comparing: • Delisted drugs with remaining or Addedmedicines • “non-essential” medicines (NEM- not listed in both NEML editions) in the same pharmacological category NEML: National Essential Medicine List

  4. OPD e-dispensing databases Statistics Statins ACEIs Anti-epileptics 9 government hospitals Segmented Regression Analysis of interrupted time series data Methodology 3 groups of Medicine Data Source: Dispensing data collected for "Data management for systematic monitoring of drug utilization and policy project"--a collaboration between IMRTA and PharReD Foundation.

  5. 10 mo 14 mo 2008 Before After NEML Methodology (cont.) 24 months time-series data points

  6. Comparison • Statins - 130,287 pt • ACEIs & AIIAs - 85,349 pt • Anti-epileptics 31,739 pt • 3 major health insurance schemes • CSMBS • SSS • UC Methodology (cont.)

  7. Results

  8. Utilization Patterns across Health Insurance Scheme

  9. No statistical significant changes in the utilization patterns of the listed, delisted and non-listed medicines occurred after the introduction of the 2008 NEML NS Discrepancies in utilization were found among patients in different health insurance systems. Sig . It appears that health insurance policy exerts greater influence on utilization patterns than essential medicine policy. Ans. Conclusion

  10. Thank You ! Acknowledgement: Institute of Medical Research Technology Assessment (IMRTA) and Pharmaceutical System Research & Development Foundation (PharReD Foundation)

More Related